Ryan Bunch
Optometrist · Rogers, ARNPI 1306225214
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,644, 6.2 times the $264 reported in 2019. Among optometrist clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 151 payments — averaging $34.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$940
- AbbVie$857
- Johnson & Johnson Vision Care, Inc.$737
- Alcon$658
- Bausch & Lomb Americas Inc.$608
- Biotissue Holdings Inc.$441
- plus $984 from 15 others
What the payments were for
- Food & beverage$5,16399%
- Entertainment$621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 11 | $940 |
| AbbVie(2 entities) | 38 | $857 |
| Johnson & Johnson Vision Care, Inc. | 26 | $737 |
| Alcon | 14 | $658 |
| Bausch & Lomb Americas Inc. | 23 | $608 |
| Biotissue Holdings Inc. | 7 | $441 |
| Rxsight Inc | 6 | $205 |
| Omeros Corporation | 1 | $125 |
| Tarsus Pharmaceuticals, Inc. | 6 | $104 |
| Rayner Intraocular Lenses Limited | 1 | $95 |
| Coopervision Inc. | 5 | $87 |
| Regeneron | 1 | $71 |
| Optos, Inc. | 1 | $62 |
| Eyevance Pharmaceuticals LLC | 2 | $39 |
| Kala Pharmaceuticals, Inc. | 2 | $38 |
| Sun Pharmaceutical Industries Inc. | 2 | $35 |
| Mallinckrodt Enterprises LLC | 1 | $32 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| Ocular Therapeutix, Inc. | 1 | $28 |
| Dompe US, Inc. | 1 | $18 |
| Carl Zeiss Meditec, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KXL System$250
- Photrexa$250
- Photrexa Viscous and Photrexa$164
- Clareon$156
- OMIDRIA$125
- VUITY$125
- MIEBO$122
- VYZULTA$122
- RXSIGHT INJECTOR HANDPIECE$113
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$113
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$113
- RXSIGHT INJECTOR CARTRIDGE$113
- RXSIGHT CONTACT LENS$113
- TOTAL30$110
- ACTIVEFOCUS$107
- ReSTOR$107
- Hydrus Microstent$100
How this compares
$5,226 in reported general payments places this provider in the 95th percentile of 442 optometrist providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 113 | $3,867 |
| ValacyclovirValacyclovir Hcl | 45 | $2,586 |
| Loteprednol Etabonate | 18 | $2,197 |
| Difluprednate | 11 | $1,372 |
| Fluorometholone | 16 | $1,065 |
| MoxifloxacinMoxifloxacin Hcl | 35 | $916 |
| Timolol Maleate | 17 | $545 |
| Ketorolac Tromethamine | 30 | $450 |
| ErythromycinErythromycin Base | 20 | $226 |
| Latanoprost | 16 | $220 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 17 | $202 |
| Ofloxacin | 18 | $201 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 21 | $161 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 18 | $117 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Rogers
- Christopher MorrisRogers$6K
- Alex BellRogers$5K
- Christina ThompsonRogers$3K
- Belinda StarkeyRogers$3K
- Kory AllenRogers$3K
- Stephanie MossRogers$3K
- Pete ParentiRogers$3K
- Christen CoatsFayetteville$216K
- Russell SimmonsBenton$6K
- Andrea HorneTontitown$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.